Genomics and Prognosis in GI Cancers

National Health Research Institutes, Taiwan

Status: Enrolling

Conditions: GI Cancer; Liver Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05767697

A-ER-109-073

Details and patient eligibility

About

This study aims to collect biospecimens and explore the correlation of genomics and prognosis in alimentary tract cancers.

Full description

In this study, the investigators will collect clinical specimens of alimentary tract cancers and perform DNA and RNA analysis to identify genetic alterations for the development of a comprehensive somatic mutation databases and investigate their potential correlation with clinical, radiological and pathological variables. The genomics study included but not limited to target gene panel sequencing, whole exome sequencing, whole genome sequencing, bulk RNA sequencing, single cell RNA sequencing and metagenomics.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Able to sign the informed consent
• Age >= 20
• Histology proved pancreatic cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer
• Agree to provide tumor/normal tissue including but not limited to surgical specimen, biopsy, cytology specimen, bile, urine or stool
• Agree to receive blood sampling 20ml at first time and 10ml during each follow-up (total sampling amount no more than 30ml per month)

Exclusion criteria

• Cannot cooperate with blood sampling